THERAPEUTIC POTENTIAL OF CARBOXYTHERAPY AND ITS IMPACT ON THE PATHOGENESIS AND SYMPTOMS OF COVID-19
Open Access
- 30 March 2022
- journal article
- research article
- Published by LLC Information and Research Center Likarska Sprava in Likars'ka Sprava
- No. 1-2,p. 5-13
Abstract
Corona virus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus and its mutants. COVID-19 is often the cause of the development of pathologies on the part of the respiratory system against the background of hypoxia. One of the alternative methods of eliminating hypoxia is carboxytherapy, since carbon dioxide (CO2) has an anti-hypoxic, antioxidant effect due to its physiological properties. The use of CO2 in the treatment can be effective in eliminating the symptoms of pleuropulmonary pathology, as CO2 has anti-inflammatory, antiviral and antimicrobial effects.Keywords
This publication has 13 references indexed in Scilit:
- Treatment for severe acute respiratory distress syndrome from COVID-19The Lancet Respiratory Medicine, 2020
- Virus and bacteria inactivation by CO2 bubbles in solutionnpj Clean Water, 2019
- Gases for establishing pneumoperitoneum during laparoscopic abdominal surgeryCochrane Database of Systematic Reviews, 2017
- Carboxytherapy is an alternative of traditional pharmacotherapyClinical pharmacy, 2016
- Effects of inhaled CO administration on acute lung injury in baboons with pneumococcal pneumoniaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2015
- Differential Effects of Buffered Hypercapnia versus Hypercapnic Acidosis on Shock and Lung Injury Induced by Systemic SepsisAnesthesiology, 2009
- The potential use of carbon dioxide as a carrier gas for drug delivery into open woundsMedical Hypotheses, 2009
- The effects of CO2 on cytokine concentrations in endotoxin-stimulated human whole bloodCritical Care Medicine, 2008
- Carbon dioxide inhibits the growth rate of Staphylococcus aureus at body temperatureSurgical Endoscopy, 2004
- Non‐thermal bacterial inactivation with dense CO2Biotechnology and Bioengineering, 2003